Literature DB >> 9199894

Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5' CpG island.

Y Huang1, J Peng, L W Oberley, F E Domann.   

Abstract

Manganese superoxide dismutase (MnSOD) enzyme activity and SOD2 gene expression have often been reported to decrease during the development of cancer. SOD2 has also been implicated as a candidate tumor suppressor gene for human malignant melanoma. Genomic DNA methylation patterns are also known to change during carcinogenesis and serve as a mechanism for tumor suppressor gene inactivation. We hypothesized that decreased SOD2 gene expression in some malignant cell populations may be due, at least in part, to methylation of upstream transcriptional regulatory sequences in the SOD2 gene. To test this hypothesis we transfected methylated and unmethylated SOD/2-CAT promoter-reporter constructs in cells known to express the SOD2 gene. Our results indicate that methylation of specific cytokines in the SOD2 5' flanking region is sufficient to repress transcriptional activity of the SOD2 promoter by at least 50%. Moreover, we show that this transcriptional repression was likely mediated by inhibition of AP-2 DNA binding and transactivation from a methylated AP-2 binding site in the SOD2 promoter. DNA methylation may provide a mechanism for transcriptional inactivation of the SOD2 gene during the development of some cancers.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199894     DOI: 10.1016/s0891-5849(97)00095-6

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  13 in total

1.  Epigenetic inactivation of galanin receptor 1 in head and neck cancer.

Authors:  Kiyoshi Misawa; Yo Ueda; Takeharu Kanazawa; Yuki Misawa; Ilwhan Jang; John Chadwick Brenner; Tetsuya Ogawa; Satoru Takebayashi; Reidar A Grenman; James G Herman; Hiroyuki Mineta; Thomas E Carey
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

2.  Chronic Ethanol Metabolism Inhibits Hepatic Mitochondrial Superoxide Dismutase via Lysine Acetylation.

Authors:  Mohammed A Assiri; Samantha R Roy; Peter S Harris; Hadi Ali; Yongliang Liang; Colin T Shearn; David J Orlicky; James R Roede; Matthew D Hirschey; Donald S Backos; Kristofer S Fritz
Journal:  Alcohol Clin Exp Res       Date:  2017-09-14       Impact factor: 3.455

Review 3.  Cross talk between mitochondria and NADPH oxidases.

Authors:  Sergey Dikalov
Journal:  Free Radic Biol Med       Date:  2011-07-06       Impact factor: 7.376

Review 4.  Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis.

Authors:  Nadine Hempel; Pauline M Carrico; J Andres Melendez
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

5.  Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure.

Authors:  George W Woodfield; Michael J Hitchler; Yizhen Chen; Frederick E Domann; Ronald J Weigel
Journal:  Clin Cancer Res       Date:  2009-05-19       Impact factor: 12.531

6.  Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells.

Authors:  Michael J Hitchler; Larry W Oberley; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2008-09-18       Impact factor: 7.376

Review 7.  Regulation of superoxide dismutase genes: implications in disease.

Authors:  Lu Miao; Daret K St Clair
Journal:  Free Radic Biol Med       Date:  2009-05-25       Impact factor: 7.376

Review 8.  Regulation of SOD2 in cancer by histone modifications and CpG methylation: closing the loop between redox biology and epigenetics.

Authors:  Anthony R Cyr; Michael J Hitchler; Frederick E Domann
Journal:  Antioxid Redox Signal       Date:  2012-10-18       Impact factor: 8.401

Review 9.  Mitochondrial dysfunction in cancer.

Authors:  Kinga Księżakowska-Łakoma; Monika Żyła; Jacek R Wilczyński
Journal:  Prz Menopauzalny       Date:  2014-05-21

Review 10.  Modulation of MnSOD in Cancer:Epidemiological and Experimental Evidence.

Authors:  Aekyong Kim
Journal:  Toxicol Res       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.